A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study
一项多中心III期前瞻性随机试验，比较高剂量表柔比星联合环磷酰胺（EC）与多西他赛序贯EC治疗淋巴结阳性乳腺癌的疗效。GOIM（意大利南部肿瘤研究组）9902研究
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdr412
Vici, P; Brandi, M; Giotta, F; Foggi, P; Schittulli, F; Di Lauro, L; Gebbia, N; Massidda, B; Filippelli, G; Giannarelli, D; Di Benedetto, A; Mottolese, M; Colucci, G; Lopez, M
